machineMD-neos4-1

neos_r_Logo_neg

Quantitative Pupillometry

neos® binocular pupillometer provides an objective assessment of pupil responses, including measurements of efferent pupillary function and an automated swinging flashlight test

rapd neoscore -62

The RAPD neoscore™ enables neos® to provide quantified results based on objective tests, supporting the analysis of relative afferent pupillary defects.

Keep reading to find out what it means and why it matters.

Manual swinging flashlight tests only correctly estimate 40% of RAPD magnitudes2. Automated testing of RAPD using a VR-headset and eye-tracking reaches non-inferior performance compared with assessment by senior neuro-ophthalmologists3. Quantitative pupillometry can therefore provide reliable measurements with a low error rate, assessing variables including pupil size, constriction amplitude, and response latency.

neos® uses an automated, digitalized version of the swinging flashlight test: simultaneously measuring direct and consensual pupil responses with a period of 3 seconds.

2Boucher T, Fortin É, Evoy F. The standard swinging flashlight test: reliable or not (P1.9-009). Neurology. 2019; 92(15 Supplement): P1.9–009.

3https://www.machinemd.com/news/study-shows-great-potential-to-automate-quantitative-pupillometric-tests

Three Scenarios. Clear Results

Whether an RAPD is present in the right eye, left eye, or not at all — the measurement results are clear, data-driven, and easy to interpret.

On the right, we showcase three typical measurement scenarios demonstrating the performance of the RAPD neoscore™ algorithm.

Right RAPD
Left RAPD
no RAPD

Efferent pupillary function 

neos® systematically presents visual stimuli to both eyes individually and together, measuring the resulting eye movements and pupillary changes of each eye, and charting this data in an examination report.

Efferent pupillary function can be assessed quickly, reliably, and objectively in an immersive VR environment with neos®. The head-mounted display minimizes the influence of ambient light, removing the need to darken an examination room.

neos® continuously measures the pupil size of both eyes in real-time with high precision. This sequence is repeated to ensure consistent and meaningful results.

exam_step_4_efferent copy
Pupillography helps to quickly appreciate pupil dynamics in addition to measurement values
Conference presentation

Acute Horner Syndrome identified by Pupillography revealing Internal Carotid Artery Dissection

Victoria Borisova, Muriel Dysli

European Neuro-Ophthalmology Society (EUNOS) Meeting, 2026
doi: 10.1080/01658107.2026.2651025View publication

Study details

Introduction

Acute anisocoria with ipsilateral ptosis, particularly when the pupillary asymmetry is greater in the dark, should raise suspicion for
Horner syndrome and prompt urgent evaluation for potentially life-threatening causes such as internal carotid artery (ICA) dissection. Early recognition in the neuro-ophthalmology setting is critical to prevent cerebral ischemic complications.

Case Report

  • A 38-year-old woman presented with a smaller right pupil and mild right ptosis for 5 days, accompanied by right neck pain and facial pressure. She had recently been physically active. Exam showed right miosis (more pronounced in dim light) with briskly reactive pupils and mild ptosis.
  • Pupillography (neos® system) demonstrated a clear right-sided dilatation lag, providing objective confirmation of oculosympathetic dysfunction. Pharmacological testing for Horner syndrome was not pursued because the lopidine test could not be realiably interpreted in cases of recent onset.

  • Contrast-enhanced computed tomography (CT) of the head and CT angiography (CTA) revealed a short-segment mural hematoma consistent with right ICA dissection, extending from the distal cervical segment to the transition into the petrous segment. No intracranial hemorrhage or cerebral ischemia was detected.

Management

  • The patient was admitted for monitoring and started on antiplatelet therapy with Aspirin 100mg.
  • Cervical artery duplex ultrasound showed no significant stenosis
  • With no signs of connective tissue disorder and a history of intense physical activity, the dissection was considered likely provoked.
  • MR angiography (MRA) at 6-month follow-up showed normalization of the vessel lumen.

Discussion

  • Acute Horner syndrome with ipsilateral neck/facial pain is a classic red flag for ICA dissection.
  • As pupillary findings may be subtle, objective testing (e.g., pupillography) can support clinical suspicion, expedite emergency imaging, and occasionally a pharmacologic testing is not necessary any more due to the characteristic appearance with dilation lag in pupillography.
  • Prompt vascular imaging with CTA or MRA is essential for diagnosis.
  • Early antithrombotic therapy (antiplatelet or anticoagulaton, depending on clinical context) reduces thromboembolic and ischemic risk.
  • Painful acute Horner syndrome should be treated as an emergency until ICA dissection is excluded.

neos gives confidence assessing pupils

.. in support of clinical decision making due to reliable data.

... by supporting smoother workflows and helping reduce the chance of errors in daily operations.

... in support of identifying signs early, reducing uncertainty for both clinicians and patients and enabling faster interventions.

 

… in easier tracking, monitoring, and comparison of results over time, ensuring consistent and reliable documentation.

 

... in easy adoption across teams, enhancing accessibility and ensuring smooth integration into diverse clinical settings.

 

… in reliable documentation and streamlined workflows, ensuring future-proof operations with seamless cloud-based solutions.

Dive into our latest studies and market research.

 

In addition to quantitative pupillometry, neos® provides a comprehensive assessment of eye alignment, eye movements, and more.

 

machineMD is proud to work with clinical partners around the world, including

 

Get started with neos®

SWITZERLAND

Our partners at Von Hoff AG are ready to help you get started with neos®  in Switzerland.

Von-Hoff-Logo
Europe

neos® is certified as a Class IIa medical device under the EU-MDR, and registered with the MHRA in the UK. 

USA

neos® is a Class I medical device registered in the US. Our team at machineMD Inc. is based in Boston, MA. .

Contact Us

For all other markets, and to find out more about research collaborations with machineMD, please complete the below form: